Skip to main content
Top
Published in: Surgical Endoscopy 10/2016

01-10-2016

Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas

Authors: Juxian Song, Yu Wang, Kuansheng Ma, Shuguo Zheng, Ping Bie, Feng Xia, Xiaowu Li, Jianwei Li, Xiaojun Wang, Jian Chen

Published in: Surgical Endoscopy | Issue 10/2016

Login to get access

Abstract

Background

There is currently no clear consensus on the relative suitabilities of laparoscopic hepatectomy (LH) and radiofrequency ablation (RFA) as minimally invasive treatment for small hepatocellular carcinoma (HCC).

Methods

In this retrospective study, we enrolled 156 patients with a single, small HCC with nodular diameters <4 cm and compared recurrence-free survival (RFS) and overall survival (OS) between patients treated with LH and control patients treated with RFA (n = 78 each). The groups were selected according to predefined criteria and matched in terms of their baseline clinical characteristics.

Results

During a median follow-up of 31.2 months, the 1-, 2-, and 3-year OS rates in the LH group were 96.2, 91.3, and 84.1 %, respectively, compared with 96.2, 82.6, and 78.8 % in the RFA group. The corresponding RFS rates were 82.1, 71.5, and 60.0 % in the LH group and 65.4, 47.7, and 37.6 % in the RFA group. Combined RFS rates were significantly higher in the LH groups (P = 0.006), but there was no significant difference in OS rates (P = 0.510). The incidence of postoperative complications was significantly lower in the RFA group (28.2 vs. 10.3 %, P = 0.004), and operation duration, intraoperative blood loss and blood transfusion, use of total parenteral nutrition, and length of stay as indicators of minimal invasiveness were also significantly better in the RFA group.

Conclusions

There was no difference between LH and RFA in terms of OS in patients with a single, small HCC. However, RFA was less invasive than the LH, but LH was associated with increased RFS.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed
2.
go back to reference Bruix J, Sherman M, Practice Guidelines Committee AAftSoLD (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRefPubMed Bruix J, Sherman M, Practice Guidelines Committee AAftSoLD (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRefPubMed
3.
4.
go back to reference Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D’Angelica MI, Blumgart LH, Dematteo RP (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617–623CrossRefPubMed Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D’Angelica MI, Blumgart LH, Dematteo RP (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617–623CrossRefPubMed
5.
go back to reference Conrad C, Ogiso S, Inoue Y, Shivathirthan N, Gayet B (2015) Laparoscopic parenchymal-sparing liver resection of lesions in the central segments: feasible, safe, and effective. Surg Endosc 29:2410–2417CrossRefPubMed Conrad C, Ogiso S, Inoue Y, Shivathirthan N, Gayet B (2015) Laparoscopic parenchymal-sparing liver resection of lesions in the central segments: feasible, safe, and effective. Surg Endosc 29:2410–2417CrossRefPubMed
6.
go back to reference Ishizawa T, Gumbs AA, Kokudo N, Gayet B (2012) Laparoscopic segmentectomy of the liver: from segment I to VIII. Ann Surg 256:959–964CrossRefPubMed Ishizawa T, Gumbs AA, Kokudo N, Gayet B (2012) Laparoscopic segmentectomy of the liver: from segment I to VIII. Ann Surg 256:959–964CrossRefPubMed
7.
go back to reference Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, Komeda K, Inoue Y, Uchiyama K (2015) Short- and long-term outcomes of laparoscopic versus open hepatectomy for small malignant liver tumors: a single-center experience. Surg Endosc 29:458–465CrossRefPubMed Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, Komeda K, Inoue Y, Uchiyama K (2015) Short- and long-term outcomes of laparoscopic versus open hepatectomy for small malignant liver tumors: a single-center experience. Surg Endosc 29:458–465CrossRefPubMed
8.
go back to reference Vibert E, Perniceni T, Levard H, Denet C, Shahri NK, Gayet B (2006) Laparoscopic liver resection. Br J Surg 93:67–72CrossRefPubMed Vibert E, Perniceni T, Levard H, Denet C, Shahri NK, Gayet B (2006) Laparoscopic liver resection. Br J Surg 93:67–72CrossRefPubMed
9.
go back to reference Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Gwak GY, Yoo BC (2013) Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97CrossRefPubMed Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Gwak GY, Yoo BC (2013) Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97CrossRefPubMed
10.
go back to reference Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST (2006) Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion. Br J Surg 93:440–447CrossRefPubMed Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST (2006) Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion. Br J Surg 93:440–447CrossRefPubMed
11.
go back to reference Poon RT, Fan ST, Tsang FH, Wong J (2002) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 235:466–486CrossRefPubMedPubMedCentral Poon RT, Fan ST, Tsang FH, Wong J (2002) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 235:466–486CrossRefPubMedPubMedCentral
12.
go back to reference Forner A, Bruix J (2012) Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol 13:750–751CrossRefPubMed Forner A, Bruix J (2012) Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol 13:750–751CrossRefPubMed
13.
go back to reference Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P (2015) Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol 62:956–967CrossRefPubMed Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P (2015) Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol 62:956–967CrossRefPubMed
14.
go back to reference Pearce NW, Di Fabio F, Abu Hilal M (2011) Laparoscopic left hepatectomy with extraparenchymal inflow control. J Am Coll Surg 213:e23–e27CrossRefPubMed Pearce NW, Di Fabio F, Abu Hilal M (2011) Laparoscopic left hepatectomy with extraparenchymal inflow control. J Am Coll Surg 213:e23–e27CrossRefPubMed
15.
go back to reference Cheung TT, Poon RT, Yuen WK, Chok KS, Jenkins CR, Chan SC, Fan ST, Lo CM (2013) Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg 257:506–511CrossRefPubMed Cheung TT, Poon RT, Yuen WK, Chok KS, Jenkins CR, Chan SC, Fan ST, Lo CM (2013) Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg 257:506–511CrossRefPubMed
16.
go back to reference Feng K, Yan J, Li X, Xia F, Ma K, Wang S, Bie P, Dong J (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802CrossRefPubMed Feng K, Yan J, Li X, Xia F, Ma K, Wang S, Bie P, Dong J (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802CrossRefPubMed
17.
go back to reference Villanueva A, Hernandez-Gea V, Llovet JM (2013) Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol 10:34–42CrossRefPubMed Villanueva A, Hernandez-Gea V, Llovet JM (2013) Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol 10:34–42CrossRefPubMed
18.
go back to reference Karabulut K, Aucejo F, Akyildiz HY, Siperstein A, Berber E (2012) Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience. Surg Endosc 26:990–997CrossRefPubMed Karabulut K, Aucejo F, Akyildiz HY, Siperstein A, Berber E (2012) Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience. Surg Endosc 26:990–997CrossRefPubMed
19.
go back to reference Tiong L, Maddern GJ (2011) Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 98:1210–1224CrossRefPubMed Tiong L, Maddern GJ (2011) Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 98:1210–1224CrossRefPubMed
20.
go back to reference Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252:903–912CrossRefPubMed Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252:903–912CrossRefPubMed
21.
go back to reference Minami Y, Kawasaki T, Kudo M, Haji S, Shiraishi O, Kawabe T, Yasuda C, Nakai T, Takeyama Y, Shiozaki H (2007) Treatment of large and/or multiple hepatic malignancies: open surgical approaches of radiofrequency ablation. Hepato-gastroenterology 54:2358–2360PubMed Minami Y, Kawasaki T, Kudo M, Haji S, Shiraishi O, Kawabe T, Yasuda C, Nakai T, Takeyama Y, Shiozaki H (2007) Treatment of large and/or multiple hepatic malignancies: open surgical approaches of radiofrequency ablation. Hepato-gastroenterology 54:2358–2360PubMed
22.
go back to reference Golfieri R, Bilbao JI, Carpanese L, Cianni R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Cappelli A, Rodriguez M, Ettorre GM, Saltarelli A, Geatti O, Ahmadzadehfar H, Haug AR, Izzo F, Giampalma E, Sangro B, Pizzi G, Notarianni E, Vit A, Wilhelm K, Jakobs TF, Lastoria S, European Network on Radioembolization with Yttrium-90 Microspheres study c (2013) Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. J Hepatol 59:753–761CrossRefPubMed Golfieri R, Bilbao JI, Carpanese L, Cianni R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Cappelli A, Rodriguez M, Ettorre GM, Saltarelli A, Geatti O, Ahmadzadehfar H, Haug AR, Izzo F, Giampalma E, Sangro B, Pizzi G, Notarianni E, Vit A, Wilhelm K, Jakobs TF, Lastoria S, European Network on Radioembolization with Yttrium-90 Microspheres study c (2013) Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. J Hepatol 59:753–761CrossRefPubMed
23.
go back to reference Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Matsuyama Y (2013) Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 58:724–729CrossRefPubMed Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Matsuyama Y (2013) Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 58:724–729CrossRefPubMed
24.
go back to reference Pompili M, Saviano A, de Matthaeis N, Cucchetti A, Ardito F, Federico B, Brunello F, Pinna AD, Giorgio A, Giulini SM, De Sio I, Torzilli G, Fornari F, Capussotti L, Guglielmi A, Piscaglia F, Aldrighetti L, Caturelli E, Calise F, Nuzzo G, Rapaccini GL, Giuliante F (2013) Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J Hepatol 59:89–97CrossRefPubMed Pompili M, Saviano A, de Matthaeis N, Cucchetti A, Ardito F, Federico B, Brunello F, Pinna AD, Giorgio A, Giulini SM, De Sio I, Torzilli G, Fornari F, Capussotti L, Guglielmi A, Piscaglia F, Aldrighetti L, Caturelli E, Calise F, Nuzzo G, Rapaccini GL, Giuliante F (2013) Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J Hepatol 59:89–97CrossRefPubMed
25.
go back to reference Xu Q, Kobayashi S, Ye X, Meng X (2014) Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma: a meta-analysis of 16,103 patients. Sci Rep 4:7252CrossRefPubMedPubMedCentral Xu Q, Kobayashi S, Ye X, Meng X (2014) Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma: a meta-analysis of 16,103 patients. Sci Rep 4:7252CrossRefPubMedPubMedCentral
26.
go back to reference Parisi A, Desiderio J, Trastulli S, Castellani E, Pasquale R, Cirocchi R, Boselli C, Noya G (2013) Liver resection versus radiofrequency ablation in the treatment of cirrhotic patients with hepatocellular carcinoma. Hepatob Pancreat Dis Int 12:270–277CrossRef Parisi A, Desiderio J, Trastulli S, Castellani E, Pasquale R, Cirocchi R, Boselli C, Noya G (2013) Liver resection versus radiofrequency ablation in the treatment of cirrhotic patients with hepatocellular carcinoma. Hepatob Pancreat Dis Int 12:270–277CrossRef
27.
go back to reference Long TCD, Bac NH, Thuan ND, Dat LT, Viet DQ, Chuong LCHQ (2014) Laparoscopic liver resection: 5-year experience at a single center. Surg Endosc Other Interv Tech 28:796–802CrossRef Long TCD, Bac NH, Thuan ND, Dat LT, Viet DQ, Chuong LCHQ (2014) Laparoscopic liver resection: 5-year experience at a single center. Surg Endosc Other Interv Tech 28:796–802CrossRef
28.
go back to reference Chen K, Chen G, Wang H, Li H, Xiao J, Duan X, He J, He K, Xiang G (2014) Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial. J Hepatol 61:1304–1311CrossRefPubMed Chen K, Chen G, Wang H, Li H, Xiao J, Duan X, He J, He K, Xiang G (2014) Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial. J Hepatol 61:1304–1311CrossRefPubMed
29.
go back to reference Feng X, Xu R, Du X, Dou K, Qin X, Xu J, Jia W, Wang Z, Zhao H, Yang S, Guo C, Liu T, Ma K (2014) Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study. Am J Gastroenterol 109:1891–1899CrossRefPubMed Feng X, Xu R, Du X, Dou K, Qin X, Xu J, Jia W, Wang Z, Zhao H, Yang S, Guo C, Liu T, Ma K (2014) Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study. Am J Gastroenterol 109:1891–1899CrossRefPubMed
30.
go back to reference Knab LM, Salem R, Mahvi DM (2013) Minimally invasive therapies for hepatic malignancy. Curr Probl Surg 50:146–179CrossRefPubMed Knab LM, Salem R, Mahvi DM (2013) Minimally invasive therapies for hepatic malignancy. Curr Probl Surg 50:146–179CrossRefPubMed
31.
go back to reference Lurje G, Lesurtel M, Clavien PA (2013) Multimodal treatment strategies in patients undergoing surgery for hepatocellular carcinoma. Dig Dis 31:112–117CrossRefPubMed Lurje G, Lesurtel M, Clavien PA (2013) Multimodal treatment strategies in patients undergoing surgery for hepatocellular carcinoma. Dig Dis 31:112–117CrossRefPubMed
Metadata
Title
Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas
Authors
Juxian Song
Yu Wang
Kuansheng Ma
Shuguo Zheng
Ping Bie
Feng Xia
Xiaowu Li
Jianwei Li
Xiaojun Wang
Jian Chen
Publication date
01-10-2016
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 10/2016
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-015-4737-1

Other articles of this Issue 10/2016

Surgical Endoscopy 10/2016 Go to the issue